基本信息
浏览量:2
职业迁徙
个人简介
Her research interest is mainly focused on cellular and molecular mechanisms of asthma and chronic obstructive pulmonary disease (COPD), understanding and developing therapies. Her major research contributions have been in the understanding of the development of b2-agonist tolerance, and the interaction between glucocorticoid receptors and b2-adrenoceptors in the intracellular signaling pathways leading to the combination therapy of long-acting inhaled b2-agonist and inhaled glucocorticoid (e.g. SymbicortÒ and SeretideÒ). She is an internationally recognized scientist in the respiratory field. She has collaborated with academic researchers, both locally and internationally on cross-disciplinary projects. She is the principal investigator and co-investigator of a number of research projects funded by RGC, HMRF and NSFC.
研究兴趣
论文共 160 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF EPIDEMIOLOGYno. 1 (2024)
ACS NANOno. 20 (2024): 13361-13376
Xin Feng,Yongyu Ye,Jianan Zhang,Yuanqiang Zhang,Sen Zhao,Judith C. W. Mak,Nao Otomo,Zhengye Zhao,Yuchen Niu,Yoshiro Yonezawa,Guozhuang Li,Mao Lin,Xiaoxin Li,Prudence Wing Hang Cheung,Kexin Xu,Kazuki Takeda,Shengru Wang,Junjie Xie,Toshiaki Kotani,Vanessa N. T. Choi,You-Qiang Song, Yang,Keith Dip Kei Luk, Kin Shing Lee,Ziquan Li, Pik Shan Li,Connie Y. H. Leung,Xiaochen Lin,Xiaolu Wang,Guixing Qiu,Kota Watanabe,Zhihong Wu,Jennifer E. Posey,Shiro Ikegawa,James R. Lupski,Jason Pui Yin Cheung,Terry Jianguo Zhang,Bo Gao,Nan Wu
B33. COVID-19, LUNG INJURY, AND SEPSIS (2024)
Biomedicine & Pharmacotherapy (2023): 114935-114935
Advances in pharmacology (San Diego, Calif.) (2023): 225-247
Annals of work exposures and healthno. Supplement_1 (2023): i55-i55
加载更多
作者统计
#Papers: 161
#Citation: 5165
H-Index: 39
G-Index: 66
Sociability: 6
Diversity: 4
Activity: 42
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn